Detailed explanation of the suitable groups and correct usage of Seleniso

Selinesol, as a new type of selective nuclear export inhibitor, has emerged in the field of anti-cancer drugs in recent years, especially in the treatment of multiple myeloma and diffuse large B-cell lymphoma. This article will elaborate on the applicable groups and correct use methods of selinesol to help patients better understand and use this drug.

1. Applicable people

Seleniso is mainly suitable for the following types of patients:

1. Patients with multiple myeloma: Selinisol can be combined with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. It may also be used in combination with dexamethasone to treat adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulators and an anti-CD38 monoclonal antibody.

2. Diffuse large B-cell lymphomaPatients with B-cell lymphoma: For adult patients with relapsed or refractory diffuse large B-cell lymphoma (including DLBCL caused by follicular lymphoma), if their disease still progresses or relapses after at least 2 systemic therapies, selinesol can be used as a new treatment option.

2. Correct use method

When using selinesol, you must strictly follow your doctor's instructions and recommended dosage to ensure the safety and effectiveness of the medication.

1. For patients with multiple myeloma:

When selinesol is used in combination with dexamethasone, the recommended dose is 80 mg taken orally on days 1 and 3 of each week.

When selinesol is used in combination with bortezomib and dexamethasone (SVd regimen), the recommended dose is 100 mg orally once weekly on the first day of each week.

2. For lymphoma patients:

The recommended dose of selinesol is 60 mg taken orally on days 1 and 3 of each week.

During the period of using selinesol, patients should pay close attention to their body's reaction and conduct regular reviews so that the doctor can adjust the treatment plan in a timely manner. At the same time, patients should also pay attention to the side effects and contraindications of the drug, and if they have any discomfort or questions, they should consult their doctor in time.

In short, selinesol, as a new anti-cancer drug, is effective for multiple myeloma and diffuse leukemiaThe treatment of B-cell lymphoma provides new options. However, since its usage and dosage vary depending on the patient's condition, it must be used under the guidance of a professional doctor. Patients should strictly abide by medical instructions to ensure the safety and effectiveness of medication. Selinisol is currently on the market in China, and patients can purchase and use it with medical advice. Generic Lucius version drugs are also sold in Laos, which are cheap and can reduce a lot of burden. Patients please choose according to their needs.